Evidence-based oncology and haematology treatments administered safely at our clinic.
All treatments are tailored individually for each patient based on diagnosis, stage, and overall health.
A standard multi-drug chemotherapy regimen used in the treatment of aggressive non-Hodgkin lymphoma, with or without rituximab (R-CHOP).
Bleomycin, Etoposide and Cisplatin (BEP) — the gold-standard chemotherapy for testicular cancer and germ cell tumours.
Standard chemotherapy combinations for colorectal and gastrointestinal cancers — administered in carefully planned infusion cycles.
The first BCR-ABL tyrosine kinase inhibitor — a landmark targeted therapy for Chronic Myeloid Leukaemia (CML) and certain GISTs.
Anti-CD20 monoclonal antibody therapy for B-cell lymphomas, CLL and autoimmune haematological conditions.
Pembrolizumab, Nivolumab and Atezolizumab — checkpoint inhibitors that unleash your immune system against cancer.
Long-term oral hormone therapy for oestrogen receptor-positive breast cancer — reducing recurrence risk for years after initial treatment.
Injectable hormonal suppression therapy for prostate cancer and hormone-sensitive breast cancer — creating a medically castrate state.
Anti-HER2 monoclonal antibody therapy for HER2-positive breast cancer and HER2+ gastric cancer — significantly improving survival.
Essential haematological diagnostic procedure for diagnosing and staging blood cancers, bone marrow failure syndromes and haematological disorders.
Proteasome inhibitor-based treatment for multiple myeloma — used in induction, consolidation and maintenance phases.
Comprehensive investigation and treatment of all forms of anaemia — iron deficiency, B12 deficiency, haemolytic, aplastic and cancer-related anaemia.
Granulocyte Colony-Stimulating Factor (G-CSF) injections to prevent or treat neutropenia during chemotherapy — reducing infection risk.
Precision blood and bone marrow analysis identifying cell surface markers — essential for diagnosing and classifying leukaemias and lymphomas.
Serial measurement of cancer-specific blood markers — CEA, CA-125, AFP, PSA, b-hCG, LDH — to monitor treatment response and detect recurrence early.
Urgent assessment and antibiotic treatment for fever in chemotherapy patients with low white cell counts — a potentially life-threatening emergency.
Carefully monitored oral chemotherapy regimens — Capecitabine, Temozolomide, Etoposide — enabling treatment in the comfort of your home.
Expert management of cancer-related pain, breathlessness, nausea and other symptoms — focused on maximising quality of life at every stage.
Structured long-term follow-up after completing cancer treatment — monitoring for recurrence, managing late effects and supporting your return to full health.
Safe, appropriately indicated blood and platelet transfusions for anaemia, thrombocytopenia and bleeding complications in cancer and haematological disorders.
Microscopic examination of blood cells for abnormalities. Quick, painless, and performed in-house.
On-site blood collection for CBC, LFT, KFT, tumour markers, and specialised tests.
For CNS involvement assessment in certain leukaemias and lymphomas. Performed under strict sterile conditions.
Sample collection and coordination with reference labs for advanced immunophenotyping of blood cancers.
Pre-transplant evaluation, donor coordination, and post-transplant follow-up for patients requiring bone marrow or stem cell transplantation at tertiary centres.
Every treatment plan is personalised. Contact us to understand what's right for you.